Find link

language:

Find link is a tool written by Edward Betts.

searching for Genmab 8 found (78 total)

alternate case: genmab

Deirdre Connelly (868 words) [view diff] exact match in snippet view article find links to article

professional. Connelly is Chairman of the Board of the European Biotech company Genmab A/S, member of the Boards of Macy’s Inc. and the Lincoln Financial Group

Amivantamab (1,894 words) [view diff] exact match in snippet view article find links to article

Retrieved 21 May 2021 – via PR Newswire. "Genmab Announces that Janssen has been Granted U.S. FDA" (Press release). Genmab A/S. 21 May 2021. Archived from the

Teclistamab (1,138 words) [view diff] exact match in snippet view article find links to article

2022. Teclistamab is the international nonproprietary name and owned by Genmab A/S (INN). "Tecvayli". Therapeutic Goods Administration (TGA). 28 June 2023

Daratumumab/hyaluronidase (986 words) [view diff] exact match in snippet view article find links to article

article incorporates text from this source, which is in the public domain. "Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab,

Acadia Pharmaceuticals (1,013 words) [view diff] exact match in snippet view article find links to article

milliarderne til at rulle". Berlingske.dk (in Danish). Retrieved 2020-11-27. "Genmab", Wikipedia, 2020-11-26, retrieved 2020-11-27 Haaning, Karen (2018-10-20)

BioMarin Pharmaceutical (1,681 words) [view diff] exact match in snippet view article find links to article

2014-02-18. "BioMarin launches LEMS drug Firdapse in European Union; and Genmab gets conditional approval for Arzerra". The Pharma Letter. 2010-04-20. Retrieved

Rituximab (5,690 words) [view diff] exact match in snippet view article find links to article

(13): 1205–1214. doi:10.2174/1389450115666141029234644. PMID 25355180. "Genmab.com / HuMax-CD20 (ofatumumab)". Archived from the original on 11 September

Cervical cancer (12,891 words) [view diff] exact match in snippet view article find links to article

original (PDF) on 21 September 2021. Retrieved 21 September 2021. "Seagen and Genmab Announce FDA Accelerated Approval for Tivdak (tisotumab vedotin-tftv) in